-
Post date
May 12, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, clinical psychedelics, clinical trials psilocybin 2021, cmps.q, COMPASS, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, filament stock, medical psychedelics, Mind Medicine Inc., MindMEd, mmed.ne, Mushrooms, Natural psilocybin extraction, naturally extracted psilocybin, pharmaceutical grade psilocybin, Psilo Scientific, psilocybin, psilocybin based therapies, psilocybin clinical trials, psilocybin market, psilocybin mushrooms, psilocybin studies, psilocybin studies 2022, Psychedelics, Today's Idea
-
Post date
April 1, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelic stock, best psychedelic stocks, best psychedelic treatment, best psychedelics companies, best psychedelics stocks, best psychedelics stocks 2021, canadian psychedelic company, clinical psychedelics, clinical trials psychedelics stocks, FH.NE, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, filament stock, invest in psychedelics 2022, mental health psychedelics, Mushrooms, Natural Psychedelic, natural psychedelic extraction, natural psychedelics, neo exchange filament, psilo health filament, Psilo Scientific, Psychedelics
-
Post date
March 23, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelics companies, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, invest in psychedelics, mushroom, Mushrooms, Patent, Patent Application, psilocybin, psychedelic formulations, psychedelic market, Psychedelics
-
Post date
March 23, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelics companies, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, invest in psychedelics, mushroom, Mushrooms, Patent, Patent Application, psilocybin, psychedelic formulations, psychedelic market, Psychedelics
-
Post date
January 25, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelic stocks, best psychedelic treatment, clinical trials psychedelics, companies doing psychedelics research, GAD, Generalized Anxiety Disorder, investing in psychedelics, LSD, LSD research, Major depressive disorder, MDD, medical psychedelics, Mind Medicine, Mind Medicine Inc., MindMEd, MNMD.Q, psychedelic assisted therapy, psychedelic market, Psychedelics, psychedelics stocks, therapy for major depression disorder